Ouster Inc SEC Filings

Ouster reported sequential strength in top-line and gross profit while remaining loss-making. Revenue for the quarter was $35.0 million, up from $27.0 million a year earlier, and six‑month revenue reached $67.7 million versus $52.9 million a year earlier, reflecting stronger product and licensing sales. Gross profit expanded to $15.8 million for the quarter, improving margins as product mix and revenue scale increased.

Despite revenue gains, the company recorded a net loss of $20.6 million for the quarter and $42.6 million for the six months. Operating expenses, particularly general and administrative costs, rose year over year. Liquidity remains a key strength: cash, cash equivalents, restricted cash and short‑term investments totaled about $229.1 million and the company raised approximately $58.5 million net from an at‑the‑market offering in the quarter. The company also recorded legal and IP‑related accruals totaling $11.7 million and disclosed ongoing patent and arbitration matters.

Ouster, Inc. filed an 8-K dated 7 Aug 2025 to disclose Item 2.02, Results of Operations and Financial Condition. The company announced its financial results for the three- and six-month periods ended 30 Jun 2025 and furnished the related press release as Exhibit 99.1. No quantitative figures are included in the filing; investors must refer to the exhibit for details. The filing also lists Item 9.01, providing exhibit indices, and confirms that the information is being furnished, not filed, thereby limiting liability under Section 18 of the Exchange Act. The document reiterates Ouster’s securities listings—common stock (OUST) on Nasdaq Global Select Market and two series of public warrants (OUSTZ, OUSTW). The report was signed by CFO Kenneth P. Gianella.

Because the 8-K contains no financial metrics or forward-looking guidance, the immediate investment impact is likely neutral; material assessment depends on the as-yet-unseen data in Exhibit 99.1.

Director Ernest E Maddock of Ouster (OUST) reported the acquisition of restricted stock units (RSUs) on June 18, 2025. The transaction details include:

• 13,558 RSUs that vest quarterly through June 18, 2026 or the next annual stockholder meeting, contingent on continued service
• 1,500 RSUs that vested immediately on grant date
• Following these transactions, Maddock directly owns 84,177 shares of common stock

Both RSU grants were awarded at $0.00 exercise price. The filing was submitted by Megan Chung as attorney-in-fact on June 20, 2025. This equity compensation grant appears to be part of the company's director compensation program, with a mix of time-based vesting and immediate vesting components.

Director Ted L. Tewksbury III of Ouster received a grant of 13,558 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Tewksbury owns a total of 127,054 shares directly.

Key details of the RSU grant:

• The RSUs will vest in quarterly installments through June 18, 2026, or until the next annual stockholder meeting, whichever comes first
• Each RSU represents the right to receive one share of common stock
• The grant was made at $0 cost to the director
• Vesting is contingent on Tewksbury's continued service with the company

This Form 4 filing was signed by Megan Chung as attorney-in-fact for Tewksbury on June 20, 2025, within the required reporting timeline for insider transactions.

Ouster Director Christina Correia Reports RSU Grant

On June 18, 2025, Ouster (OUST) Director Christina Correia received a grant of 13,558 restricted stock units (RSUs). Following this transaction, Correia's direct ownership increased to 71,690 shares.

Key details of the RSU grant:

• Each RSU represents the right to receive one share of common stock
• Vesting occurs in quarterly installments through June 18, 2026, or until the next annual stockholder meeting
• Vesting is contingent on continued service as director
• The RSUs were granted at $0 exercise price

The transaction was reported via Form 4 filing and executed through an attorney-in-fact, Megan Chung, on June 20, 2025.

Ouster director Virginia Boulet received a grant of 13,558 restricted stock units (RSUs) on June 18, 2025. The RSUs were awarded at a price of $0 and will vest in quarterly installments through the earlier of June 18, 2026 or the company's next annual meeting of stockholders, subject to continued service.

Following this transaction, Boulet now beneficially owns 221,842 shares of Ouster common stock directly. The RSUs represent a contingent right to receive one share of common stock for each unit granted.

• Transaction Type: RSU Grant (Form 4 Code: A)
• Filing Status: Individual filing by director
• Vesting Schedule: Quarterly through June 2026 or next annual meeting
• Ownership: Direct ownership

Ouster Director Susan Heystee reported acquiring 13,558 restricted stock units (RSUs) on June 18, 2025. The RSUs were granted at $0 cost and represent a contingent right to receive an equal number of common stock shares.

Key details of the transaction:

• The RSUs will vest in quarterly installments through the earlier of June 18, 2026 or the company's next annual meeting of stockholders
• Vesting is subject to Heystee's continued service as director
• Following the transaction, Heystee directly owns 90,942.3 shares of Ouster common stock
• The Form 4 was filed by attorney-in-fact Megan Chung on June 20, 2025

This equity grant appears to be part of Ouster's director compensation program, aligning the director's interests with shareholders through stock ownership.

Ouster director Stephen A. Skaggs received a grant of 13,558 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Skaggs now beneficially owns 71,690 shares directly.

Key transaction details:

• Transaction type: RSU grant at $0.00 per unit
• Vesting schedule: Quarterly installments through the earlier of June 18, 2026, or next annual stockholder meeting
• Vesting condition: Subject to continued service as director
• Each RSU represents right to receive one share of common stock

This Form 4 filing was submitted on June 20, 2025, through an attorney-in-fact. The transaction appears to be part of the company's director compensation program, as indicated by the vesting schedule aligned with the annual stockholder meeting cycle.